Literature DB >> 11136739

Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins.

M Saijo1, M Niikura, S Morikawa, T G Ksiazek, R F Meyer, C J Peters, I Kurane.   

Abstract

The full-length nucleoprotein (NP) of Ebola virus (EBO) was expressed as a His-tagged recombinant protein (His-EBO-NP) by a baculovirus system. Carboxy-terminal halves of NPs of EBO and Marburg virus (MBG) were expressed as glutathione S-transferase-tagged recombinant proteins in an Escherichia coli system. The antigenic regions on the NPs of EBO and MBG were determined by both Western blotting and enzyme-linked immunosorbent assay (ELISA) to be located on the C-terminal halves. The C-terminal 110 and 102 amino acids of the NPs of EBO and MBG, respectively, possess strong antigenicity. The full-length NP of EBO was strongly expressed in insect cells upon infection with the recombinant baculovirus, while expression of the full-length NP of MBG was weak. We developed an immunoglobulin G (IgG) ELISA using His-EBO-NP and the C-terminal halves of the NPs of EBO and MBG as antigens. We evaluated the IgG ELISA for the ability to detect IgG antibodies to EBO and MBG, using human sera collected from EBO and MBG patients. The IgG ELISA with the recombinant NPs showed high sensitivity and specificity in detecting EBO and MBG antibodies. The results indicate that ELISA systems prepared with the recombinant NPs of EBO and MBG are valuable tools for the diagnosis of EBO and MBG infections and for seroepidemiological field studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136739      PMCID: PMC87670          DOI: 10.1128/JCM.39.1.1-7.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.

Authors:  T G Ksiazek; P E Rollin; A J Williams; D S Bressler; M L Martin; R Swanepoel; F J Burt; P A Leman; A S Khan; A K Rowe; R Mukunu; A Sanchez; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

2.  The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression.

Authors:  A Sanchez; M P Kiley; B P Holloway; J B McCormick; D D Auperin
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

3.  Modifications to indirect immunofluorescence tests on Lassa, Marburg, and Ebola material.

Authors:  G van der Groen; T Kurata; C Mets
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

4.  The nucleoprotein of Marburg virus is phosphorylated.

Authors:  S Becker; S Huppertz; H D Klenk; H Feldmann
Journal:  J Gen Virol       Date:  1994-04       Impact factor: 3.891

5.  Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys.

Authors:  K M Johnson; L H Elliott; D L Heymann
Journal:  J Clin Microbiol       Date:  1981-11       Impact factor: 5.948

6.  Linearization of baculovirus DNA enhances the recovery of recombinant virus expression vectors.

Authors:  P A Kitts; M D Ayres; R D Possee
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

Review 7.  Emerging and reemerging of filoviruses.

Authors:  H Feldmann; W Slenczka; H D Klenk
Journal:  Arch Virol Suppl       Date:  1996

8.  Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections.

Authors:  C Prehaud; E Hellebrand; D Coudrier; V E Volchkov; V A Volchkova; H Feldmann; B Le Guenno; M Bouloy
Journal:  J Gen Virol       Date:  1998-11       Impact factor: 3.891

9.  Ebola haemorrhagic fever in Kikwit, Zaire. International Scientific and Technical Committee and WHO Collaborating Centre for Haemorrhagic Fevers.

Authors:  T Muyembe; M Kipasa
Journal:  Lancet       Date:  1995-06-03       Impact factor: 79.321

10.  Preliminary report: isolation of Ebola virus from monkeys imported to USA.

Authors:  P B Jahrling; T W Geisbert; D W Dalgard; E D Johnson; T G Ksiazek; W C Hall; C J Peters
Journal:  Lancet       Date:  1990-03-03       Impact factor: 79.321

View more
  35 in total

1.  Antigen capture enzyme-linked immunosorbent assay for specific detection of Reston Ebola virus nucleoprotein.

Authors:  Tetsuro Ikegami; Masahiro Niikura; Masayuki Saijo; Mary E Miranda; Alan B Calaor; Marvin Hernandez; Luz P Acosta; Daria L Manalo; Ichiro Kurane; Yasuhiro Yoshikawa; Shigeru Morikawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

Review 3.  Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.

Authors:  Masayuki Saijo; Masahiro Niikura; Tetsuro Ikegami; Ichiro Kurane; Takeshi Kurata; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2006-04

4.  Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus.

Authors:  Verena Krähling; Dirk Becker; Cornelius Rohde; Markus Eickmann; Yonca Eroğlu; Astrid Herwig; Romy Kerber; Katharina Kowalski; Júlia Vergara-Alert; Stephan Becker
Journal:  Med Microbiol Immunol       Date:  2015-10-16       Impact factor: 3.402

5.  Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus.

Authors:  Ahidjo Ayouba; Abdoulaye Touré; Christelle Butel; Alpha Kabinet Keita; Florian Binetruy; Mamadou S Sow; Vincent Foulongne; Eric Delaporte; Martine Peeters
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

6.  Recombinant nucleoprotein-based enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus.

Authors:  Masayuki Saijo; Tang Qing; Masahiro Niikura; Akihiko Maeda; Tetsuro Ikegami; Christophe Prehaud; Ichiro Kurane; Shigeru Morikawa
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

7.  Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies.

Authors:  Eri Nakayama; Ayaka Yokoyama; Hiroko Miyamoto; Manabu Igarashi; Noriko Kishida; Keita Matsuno; Andrea Marzi; Heinz Feldmann; Kimihito Ito; Masayuki Saijo; Ayato Takada
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

8.  Determination of specific antibody responses to the six species of ebola and Marburg viruses by multiplexed protein microarrays.

Authors:  Teddy Kamata; Mohan Natesan; Kelly Warfield; M Javad Aman; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2014-09-17

9.  Development of an Immunochromatography Assay (QuickNavi-Ebola) to Detect Multiple Species of Ebolaviruses.

Authors:  Reiko Yoshida; Shino Muramatsu; Hiroshi Akita; Yuji Saito; Miwa Kuwahara; Daisuke Kato; Katendi Changula; Hiroko Miyamoto; Masahiro Kajihara; Rashid Manzoor; Wakako Furuyama; Andrea Marzi; Heinz Feldmann; Aaron Mweene; Justin Masumu; Jimmy Kapeteshi; Jean-Jacques Muyembe-Tamfum; Ayato Takada
Journal:  J Infect Dis       Date:  2016-07-26       Impact factor: 5.226

10.  Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein.

Authors:  Katendi Changula; Reiko Yoshida; Osamu Noyori; Andrea Marzi; Hiroko Miyamoto; Mari Ishijima; Ayaka Yokoyama; Masahiro Kajihara; Heinz Feldmann; Aaron S Mweene; Ayato Takada
Journal:  Virus Res       Date:  2013-05-20       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.